Caribou Biosciences Appoints Scott Braunstein, M.D. to Board of Directors

BERKELEY, Calif.--(BUSINESS WIRE)--Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that it has appointed Scott Braunstein, M.D. to its board of directors. Dr. Braunstein, an accomplished leader with over 20 years of industry experience, has expertise and experience in governing, leading, and investing in biopharmaceutical companies....

Click to view original post